维普期刊资源整合服务平台（V6.5）

37篇 您的检索式：作者名="DETAINT D"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Extracelhdar matrix ~modelling in human aortic valve disease: the role of matrix metalloproteinases and their tissue inhibitors 显示文摘	Fondard O Detaint D lung B	2005	Eur Heart J2005，26，13：	1
2	Extracelhdar matrix modelling in human aortic valve disease: the role of matrix metalloproteinases and their tissue inhibitors 显示文摘	Fondard O Detaint D lung B	2005	Eur Heart J2005，26，13：	1
3	Extraeellnlar matrix remodelling in human aortic valve disease:the role of matrix metalloproteinases and their tissue inhibitors显示文摘	Fondard O Detaint D and lung B	2005	Eur Heart J2005，26，13：	1
4	Extraeellular matrix remodelling in human aortic valve disease: the role of matrix metalloproteinases and their tissue inhibitors显示文摘	Fondard O Detaint D lung B	2005	Eur Heart J2005，26，13：	1
5	B-type natriuretic peptide in organic mitral regurgitation determinants and impact on outcome显示文摘	Detaint D Messika-Zeitoun D Avierinos JF	2005	Circulation2005，111，18：	1
6	B - type natri- uretie peptide in organic mitral regurgitation: Determinants and impact on outcome 显示文摘	Detaint D Messika - Zeitoun D Avierinos JF	2005	Circulation2005，111，18：	1
7	Association of B - type natriuretic peptide activation to left ventricular end - systolic re- modeling in organic and functional mitral regurgitation 显示文摘	Detaint D Messika - Zeitoun D Chen HH	2005	Am J Car- diol2005，97，7：	1
8	Extracellular matrix remodelling in human aortic valve disease:the role of matrix metalloproteinases and their tissue inhibitors显示文摘	Detaint D Iung B	2005	Eur Heart J2005，26，13：	1
9	Extracellular matrix remodeling in human aortic valve disease:the role of matrix metalloproteinases and their tissue inhibitors显示文摘	Fondard O Detaint D Lung B	2005	Eur Heart J2005，26，：	1
10	B-type natriuretic peptide in organic mitral regurgitation determinants and impact on outcome显示文摘	Detaint D Messika-Zeitoun D Avierinos JF		0，，18：	1
11	Surgical correction of mitral regurgita- tion in the elderly: outcomes and recent improvements显示文摘	Detaint D Sundt TM Nkomo VT	2006	Circulation2006，114，4：	1
12	B-type natriuretic peptide in organic mitral regurgitation:determinants and impact on outcome显示文摘	Detaint D Messika-Zeitoun D Avierinos JF	2005	Circulation2005，111，18：	1
13	Evaluation and clinical implications of aortic valve calcification measured by electronbeam computed tomography显示文摘	Messika-Zeitoun D Aubry MC Detaint D	2004	Circulation2004，110，3：	1
14	Cardiovascular manifestations in men and women carrying a FBN1 mutation显示文摘	Detaint D Faivre L Collod-Beroud G	2010	Eur Heart J2010，31，18：	1
15	Surgical correction of mitral regurgitation in the elder- ly: outcomes and recent improvements显示文摘	DETAINT D SUNDT T M NKOMO V T	2006	Circula- tion2006，114，：	1
16	B type natriuretic peptide in organic mitral regurgitation: determinants and impact on outcome 显示文摘	Detaint D Messika-Zeitoun D Avierinos JF	2005	Circulation2005，111，18：	1
17	Acute heart failure: How to evaluate left ventricular filling pressure in practice显示文摘	Jondeaa G Detaint D	2009	Arch Cardiovasc Dis2009，102，4：	1
18	Cardiovascular manifestations in men and women carrying a FBN1 mutation 显示文摘	Detaint D Faivre L Collod-Beroud G	2010	Eur Heart J2010，31，：	1
19	Aortic event rate in the Marfan population: a cohort study 显示文摘	Jondeau G Detaint D Tubach F	2012	Circulation2012，125，：	1
20	Rationale and design of a ran- domized clinical trial (Marfan Sartan) of angiotensin II receptor blocker therapy versus placebo in individuals with Marfan syndrome显示文摘	Detaint D Aegerter P Tubach F	2010	Arch Car- diovasc Dis2010，103，5：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示